Accrued liabilities consist of the following (in thousands):
June 30,
December 31,
2026
2025
Accrued research and development-related expenses
$
1,393
1,650
Accrued clinical trial-related expenses
149
268
Accrued professional services expenses
101
84
Accrued offering costs
82
—
Other
22
50
Total accrued liabilities
1,747
2,052
No definition available.
Tabular disclosure of the components of accrued liabilities.